Churg–Strauss syndrome: retrospective study in Burgundian population in France in past 10 years
- 29 December 2009
- journal article
- research article
- Published by Springer Nature in Rheumatology International
- Vol. 31 (5) , 587-593
Abstract
Churg–Strauss Syndrome (SCS) is a systemic vasculitis associated with asthma and eosinophilia. The aim of our work is to describe this pathology in the Burgundian population in France. We counted from the hospitalisation data-processing summaries, the whole of the SCS hospitalised in Burgundy between 1998 and 2008. During the follow-up, the clinical and paraclinical characteristics of every patient were collected. The average prevalence is of 11.3 per million inhabitants and the incidence is of 1.2 new cases per million inhabitants per annum. There exists however, a great prevalence disparity and incidence amongst the various departments of the area. The patient’s average follow-up is of 7.7 years. In 23% of the cases one finds a starting factor for vasculitis. The delay between the first signs and the diagnostic is an average of 61 months. The ANCA are positive in 26% of cases and of anti-myeloperoxidase specificity in 83% of cases (P < 0.001). The most profitable biopsies are essentially cutaneous and neuromuscular. At the diagnostic, two-third of the patients have had a treatment adapted according to the current recommendations based on the Five Factor Score. The remission rate within a 1-year period is of 77%. The remission is strongly correlated to the therapeutic protocol associating corticoids and cyclophosphamide (P < 0.05). In conclusion, the prevalence of SCS in our area is similar to that observed in other European regions. However, this vasculitis remains a difficult and often a tardive diagnostic pathology.Keywords
This publication has 24 references indexed in Scilit:
- Cardiac Involvement in Churg-Strauss SyndromeMedicine, 2009
- Treatment of Churg‐Strauss syndrome without poor‐prognosis factors: A multicenter, prospective, randomized, open‐label study of seventy‐two patientsArthritis & Rheumatism, 2008
- Churg‐Strauss syndrome with poor‐prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty‐eight patientsArthritis Care & Research, 2007
- Epidemiology of Wegener's granulomatosis: Lessons from descriptive studies and analyses of genetic and environmental risk determinants.2006
- Deaths Occurring During the First Year After Treatment Onset for Polyarteritis Nodosa, Microscopic Polyangiitis, and Churg-Strauss SyndromeMedicine, 2005
- Stable incidence of primary systemic vasculitides over five years: Results from the German vasculitis registerArthritis Care & Research, 2005
- Churg-Strauss syndromeThe American Journal of Medicine, 2003
- Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centreRheumatology, 2002
- No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis registerRheumatology, 2002
- Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studiesPharmacoepidemiology and Drug Safety, 1999